The North America Deep Brain Stimulation Devices Market is expected to witness market growth of 15.4% CAGR during the forecast period (2019-2025).
Several commercially available electrodes are capable of delivering directional current, and require adjustments to a particular targeted area. This advancement helps refine the stimulation paradigms and avoid unwanted DBS side effects. Additionally, while most DBS systems include a constant train of electrical stimulations, there is increasing interest in closed-loop DBS in which stimulation is turned on the basis of detecting the presence of a pathological physiological signal. Some of the signals might include the occurrence of an electroencephalographic abnormality in patients with epilepsy43 or the increase in oscillatory activity in patients with PD.
In the United States alone, the total direct and indirect costs of Parkinson's in the United States have determined costs equivalent to billions of dollars that include treatment, disability, and related expenses, along with the lost income due to the inability of the patients to work. This has prompted the original equipment manufacturers (OEMs) to build cost-effective tools for the treatment of neurological movement disorders, combined with unpredictable economic conditions in the United States. In 2015, the US Food and Drug Administration (FDA) approved deep brain stimulation (DBS) system to treat Parkinson's disease and essential tremor, called Brio System.
Based on Application, the market is segmented into Bronchoscopy, GI endoscopy, ENT Endoscopy, Urologic endoscopy, Arthroscopy and Others. Based on End Use, the market is segmented into Diagnostic Centers, Clinics and Hospitals. Based on Applications, the market is segmented into Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications. Based on End User, the market is segmented into Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation, Ltd., Beijing PINS Medical Co., Ltd., NeuroPace, Inc., Nevro Corporation, Neuronetics, Inc., and Fisher Wallace Laboratories, Inc.
Scope of the Study
Market Segmentation:
By Application
By End Use
By Applications
By End User
By Country
Companies Profiled
Unique Offerings from the Publisher
Several commercially available electrodes are capable of delivering directional current, and require adjustments to a particular targeted area. This advancement helps refine the stimulation paradigms and avoid unwanted DBS side effects. Additionally, while most DBS systems include a constant train of electrical stimulations, there is increasing interest in closed-loop DBS in which stimulation is turned on the basis of detecting the presence of a pathological physiological signal. Some of the signals might include the occurrence of an electroencephalographic abnormality in patients with epilepsy43 or the increase in oscillatory activity in patients with PD.
In the United States alone, the total direct and indirect costs of Parkinson's in the United States have determined costs equivalent to billions of dollars that include treatment, disability, and related expenses, along with the lost income due to the inability of the patients to work. This has prompted the original equipment manufacturers (OEMs) to build cost-effective tools for the treatment of neurological movement disorders, combined with unpredictable economic conditions in the United States. In 2015, the US Food and Drug Administration (FDA) approved deep brain stimulation (DBS) system to treat Parkinson's disease and essential tremor, called Brio System.
Based on Application, the market is segmented into Bronchoscopy, GI endoscopy, ENT Endoscopy, Urologic endoscopy, Arthroscopy and Others. Based on End Use, the market is segmented into Diagnostic Centers, Clinics and Hospitals. Based on Applications, the market is segmented into Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications. Based on End User, the market is segmented into Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation, Ltd., Beijing PINS Medical Co., Ltd., NeuroPace, Inc., Nevro Corporation, Neuronetics, Inc., and Fisher Wallace Laboratories, Inc.
Scope of the Study
Market Segmentation:
By Application
- Bronchoscopy
- GI endoscopy
- ENT Endoscopy
- Urologic endoscopy
- Arthroscopy and
- Others
By End Use
- Diagnostic Centers
- Clinics and
- Hospitals
By Applications
- Parkinson's disease
- Epilepsy
- Essential Tremor
- Dystonia
- Obsessive Compulsive Disorder and
- Other Applications
By End User
- Neurological Clinics
- Ambulatory Surgical Centers
- Hospital and
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Aleva Neurotherapeutics SA
- Functional Neuromodulation, Ltd.
- Beijing PINS Medical Co., Ltd.
- NeuroPace, Inc.
- Nevro Corporation
- Neuronetics, Inc.
- Fisher Wallace Laboratories, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Deep Brain Stimulation Devices Market by Applications
Chapter 4. North America Deep Brain Stimulation Devices Market by End Users
Chapter 5. North America Deep Brain Stimulation Devices Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Aleva Neurotherapeutics SA
- Functional Neuromodulation, Ltd.
- Beijing PINS Medical Co., Ltd.
- NeuroPace, Inc.
- Nevro Corporation
- Neuronetics, Inc.
- Fisher Wallace Laboratories, Inc.
Methodology
LOADING...
